Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?

Iman F. Montasser; Mohamed A. Sakr; Hany M. Dabbous; Kareem Abdelaziz; Hend Ebada; Yasmine M. Massoud; Mohamed Bahaa; Hany Said; Kamal Mamdouh; Mahmoud S. El Meteini

doi:10.1097/01.elx.0000546496.60509.bf

Q2 2018

Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?

Iman F. Montasser · Mohamed A. Sakr · Hany M. Dabbous · Kareem Abdelaziz · Hend Ebada · Yasmine M. Massoud · Mohamed Bahaa · Hany Said · Kamal Mamdouh · Mahmoud S. El Meteini

10.1097/01.elx.0000546496.60509.bf 387 Views 0 Citations

Citations

387

Views

Abstract not available for this publication.

Cite this Article (APA)

Iman, F. M., Mohamed, A. S., Hany, M. D., Kareem, A., Hend, E., Yasmine, M. M., Mohamed, B., Hany, S., Kamal, M., Mahmoud, S. E. M. (2018). Early treatment of recurrent hepatitis C virus infection after liver transplantation in the era of direct-acting antivirals, what we have learned till now?. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000546496.60509.bf